The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy

Acta Oncologica

Volumn 48, Issue 2, 2009, Pages 238-244

  Søndergaard, Jimmi ^a   Høyer, Morten ^a   Petersen, Jørgen B ^a   Wright, Pauliina ^a   Grau, Cai ^a   Muren, Ludvig Paul ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DYSURIA; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; PELVIS LYMPH NODE; PRIORITY JOURNAL; RADIATION DOSE; TISSUE DIFFERENTIATION; URINARY FREQUENCY; UROGENITAL TRACT DISEASE;

AGED; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; INTESTINES; LYMPH NODES; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PELVIS; RADIATION INJURIES; RADIATION PROTECTION; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 60549099224     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860802251575     Document Type: Article

References (28)

1. Intensity Modulated Radiation Therapy Collaborative Working Group. Intensity-modulated radiotherapy: Current status and issues of interest. Int J Radiat Oncol Biol Phys 2001;51:880-914.
2. Nutting CM, Convery DJ, Cosgrove VP, Rowbottom C, Pachani AR, Webb S, et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys 2000;48:649-56.
3. Jani AB, Su A, Milano MT. Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: Analysis of acute toxicity. Urology 2006;67:147-51.
4. Muren LP, Redpath AT, McLaren D, Mclaren D, Rorvik J, Halvorsen OJ, et al. A concomitant tumour boost in bladder irradiation: Patient suitability and the potential of intensity-modulated radiotherapy. Radiother Oncol 2006;80:98-105.
5. Wang-Chesebro A, Xia P, Coleman J, Akazawa C, Roach III M. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2006;66:654-62.
6. Sengeløv L, von der Maase H. Radiotherapy in bladder cancer. Radiother Oncol 1999;52:1-14.
7. Fokdal L, Høyer M, von der Maase H. Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer. Acta Oncol 2004;43:749-57.
8. Fokdal L, Høyer M, Meldgaard P, et al. Long-term bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer. Radiother Oncol 2004;72:139-45.
9. Muren LP, Smaaland R, Dahl O. Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiother Oncol 2003;69:291-304.
10. Fokdal L, Honore H, Høyer M, Meldgaard P, Fode K, von der Maase H. Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer. Int J Radiat Oncol Biol Phys 2004;59:436-44.
11. Redpath AT, Muren LP. CT-guided intensity-modulated radiotherapy for bladder cancer: Isocentre shifts, margins and their impact on target dose. Radiother Oncol 2006;81:276-83.
12. Niemierko A. Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med Phys 1997;24:103-10.
13. Hysing LB, Skorpen TN, Alber M, Fjellsbø LB, Helle SI, Muren LP. On the influence of organ motion on conformal versus intensity-modulated pelvic radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2008;71:1496-1503.
14. Roeske JC, Bonta D, Mell LK, Lujan AE, Mundt AJ. A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy. Radiother Oncol 2003;69:201-7.
15. Söhn M, Yan D, Liang J, Meldolesi E, Vargas C Alber M. Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models. Int J Radiat Oncol Biol Phys 2007;67:1066-73.
16. Wu Q, Mohan R, Morris M, Lauve A, Schmidt-Ulrich R. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: Dosimetric results. Int J Radiat Oncol Biol Phys 2003;56:573-85.
17. Dice LR. Measures of the amount of ecologic association between species. Ecology 1945;26:297-302.
18. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
19. Koper PCM, Stroom JC, van Putten WLJ, Korevaar A, Gert A, Heijmen BJM, et al. Acute morbidity reduction using 3DCRT for prostate carcinoma: A randomized study. Int J Radiat Oncol Biol Phys 1999;43:727-34.
20. Knap MM, Lundbeck F, Overgaard J. The role of pelvic lymph node dissection as a predictive and prognostic factor in bladder cancer. Eur J Cancer 2003;39:604-13.
21. Muren LP, Wasbø E, Helle SI, Hysing LB, Karlsdottir A, Odland OH, et al. Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: Planning procedures and early experiences. Int J Radiat Oncol Biol Phys 2008;71:1034-1041.
22. Ashman J, Zelefsky M, Hunt M, Leibel SA, Fuks Z. Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2005;63:765-71.
23. Park CS, Kim Y, Lee N, Bucci KM, Quivey JM, Verhey CJ, et al. Method to account for dose fractionation in analysis of IMRT plans: Modified equivalent uniform dose. Int J Radiat Oncol Biol Phys 2005;62:925-32.
24. Tonoli S, Bertoni F, De Stefani A, Vital E, De Tomasi D, Caraffini B, et al. Radical radiotherapy for bladder cancer: Retrospective analysis of a series of 459 patients treated in an Italian institution. Clin Oncol 2006;18:52-9.
25. Guckenberger M, Baier K, Richter A, Vordemark D, Flentje M. Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only? Radiat Oncol 2008;3: Article No. 3.
26. Hysing LB, Kvinnsland Y, Lord H, Muren LP. Planning organ at risk volume margins for organ motion of the intestine. Radiother Oncol 2006;80:349-54.
27. Burridge N, Amer A, Marchant T, Sykes J, Stratford J, Henry A, et al. Online adaptive radiotherapy of the bladder: Small bowel irradiated-volume reduction. Int J Radiat Oncol Biol Phys 2006;66:892-7.
28. Pos FJ, Hulshof M, Lebesque J, Lots H, Van Tienhoven G, Moonen L, et al. Adaptive radiotherapy for invasive bladder cancer: A feasibility study. Int J Radiat Oncol Biol Phys 2006;64:862-8.